Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
- 1 September 2005
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 11 (9), 690-703
- https://doi.org/10.1111/j.1469-0691.2005.01217.x
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Tratamiento antibiótico intravenoso domiciliario en las unidades de fibrosis quística de la Comunidad de MadridMedicina Clinica, 2004
- Whole-Genome Sequence Variation among Multiple Isolates of Pseudomonas aeruginosaJournal of Bacteriology, 2003
- Utility of Gram Staining for Evaluation of the Quality of Cystic Fibrosis Sputum SamplesJournal of Clinical Microbiology, 2002
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Macrolide antibiotics and cystic fibrosisThorax, 2002
- Effect of continuous antistaphylococcal therapy on the rate ofP. aeruginosa acquisition in patients with cystic fibrosisPediatric Pulmonology, 2001
- Home intravenous antibiotics for cystic fibrosisPublished by Wiley ,2000
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosisThe Journal of Pediatrics, 1988